Xue Y[au] - Search Results

Year	Number of Results
1979	2
1981	1
1983	1
1984	3
1985	4
1986	2
1987	3
1988	8
1989	5
1990	9
1991	12
1992	9
1993	17
1994	23
1995	19
1996	32
1997	34
1998	29
1999	29
2000	50
2001	43
2002	64
2003	78
2004	105
2005	115
2006	105
2007	161
2008	167
2009	199
2010	242
2011	294
2012	349
2013	337
2014	413
2015	487
2016	548
2017	581
2018	711
2019	838
2020	1012
2021	1151
2022	1269
2023	14

1

Molecular signatures underlying neurofibrillary tangle susceptibility in Alzheimer's disease.

Otero-Garcia M, Mahajani SU, Wakhloo D, Tang W, Xue YQ, Morabito S, Pan J, Oberhauser J, Madira AE, Shakouri T, Deng Y, Allison T, He Z, Lowry WE, Kawaguchi R, Swarup V, Cobos I. Otero-Garcia M, et al. Among authors: xue yq. Neuron. 2022 Sep 21;110(18):2929-2948.e8. doi: 10.1016/j.neuron.2022.06.021. Epub 2022 Jul 25. Neuron. 2022. PMID: 35882228

2

Rescue of autosomal dominant hearing loss by in vivo delivery of mini dCas13X-derived RNA base editor.

Xiao Q, Xu Z, Xue Y, Xu C, Han L, Liu Y, Wang F, Zhang R, Han S, Wang X, Li GL, Li H, Yang H, Shu Y. Xiao Q, et al. Among authors: xue y. Sci Transl Med. 2022 Jul 20;14(654):eabn0449. doi: 10.1126/scitranslmed.abn0449. Epub 2022 Jul 20. Sci Transl Med. 2022. PMID: 35857824

3

Retraction Note to: Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.

Yu M, Xue Y, Zheng J, Liu X, Yu H, Liu L, Li Z, Liu Y. Yu M, et al. Among authors: xue y. Mol Cancer. 2022 Sep 29;21(1):188. doi: 10.1186/s12943-022-01660-3. Mol Cancer. 2022. PMID: 36175912 Free PMC article. No abstract available.

4

Retraction Notice to: Role of HCP5-miR-139-RUNX1 Feedback Loop in Regulating Malignant Behavior of Glioma Cells.

Teng H, Wang P, Xue Y, Liu X, Ma J, Cai H, Xi Z, Li Z, Liu Y. Teng H, et al. Among authors: xue y. Mol Ther. 2022 Jul 6;30(7):2638. doi: 10.1016/j.ymthe.2022.03.019. Epub 2022 May 24. Mol Ther. 2022. PMID: 35797980 Free PMC article. No abstract available.

5

Wound-Induced Hair Neogenesis Model.

Xue Y, Lim CH, Plikus MV, Ito M, Cotsarelis G, Garza LA. Xue Y, et al. J Invest Dermatol. 2022 Oct;142(10):2565-2569. doi: 10.1016/j.jid.2022.07.013. J Invest Dermatol. 2022. PMID: 36153062 Free PMC article. Review.

6

Simulating domain architecture evolution.

Cui X, Xue Y, McCormack C, Garces A, Rachman TW, Yi Y, Stolzer M, Durand D. Cui X, et al. Among authors: xue y. Bioinformatics. 2022 Jun 24;38(Suppl 1):i134-i142. doi: 10.1093/bioinformatics/btac242. Bioinformatics. 2022. PMID: 35758772 Free PMC article.

7

Representation of women in ophthalmology journal editorial boards.

Park J, Xue Y, Lim M, Tretiakov N, Felfeli T. Park J, et al. Among authors: xue y. BMJ Open Ophthalmol. 2022 Oct;7(1):e001127. doi: 10.1136/bmjophth-2022-001127. Epub 2022 Oct 3. BMJ Open Ophthalmol. 2022. PMID: 36318698 Free PMC article. No abstract available.

8

Nanodevices for deep cartilage penetration.

Xu XL, Xue Y, Ding JY, Zhu ZH, Wu XC, Song YJ, Cao YL, Tang LG, Ding DF, Xu JG. Xu XL, et al. Among authors: xue y. Acta Biomater. 2022 Oct 12:S1742-7061(22)00663-8. doi: 10.1016/j.actbio.2022.10.007. Online ahead of print. Acta Biomater. 2022. PMID: 36243371 Review.

9

Cutting-Edge Methods for Better Understanding Cells.

Xue Y. Xue Y. Cells. 2022 Nov 3;11(21):3479. doi: 10.3390/cells11213479. Cells. 2022. PMID: 36359875 Free PMC article.

10

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest.

Yuan Y, Wang C, Zhuang X, Lin S, Luo M, Deng W, Zhou J, Liu L, Mao L, Peng W, Chen J, Wang Q, Shu Y, Xue Y, Huang P. Yuan Y, et al. Among authors: xue y. Nat Commun. 2022 Sep 6;13(1):5237. doi: 10.1038/s41467-022-32976-9. Nat Commun. 2022. PMID: 36068222 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results